| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Canadian Institutes for Health Research Group in Fetal and Neonatal Health and Development, Departments of Physiology and Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Address all correspondence and requests for reprints to: Falguni A. Patel, M.D., 1 Kings College Circle, Medical Sciences Building, Room 3344, Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada. E-mail: fal.patel{at}utoronto.ca
Abstract
PGs mediate parturition events. 15-Hydroxyprostaglandin dehydrogenase (PGDH) catalyzes the first step in the metabolism of PGs to render them inactive. We have reported previously that cortisol (F) decreases PGDH activity and progesterone (P4) maintains PGDH in human chorion and placenta at term. To study the interaction of P4 and F on the regulation of PGDH, we treated chorion and placental trophoblast cells in culture with combinations of F, dexamethasone, P4, trilostane, and medroxyprogesterone acetate (MPA). Following a 24-h steroid treatment period and 4-h PGF2
challenge, culture media and cells were collected for measurement of PGF2
levels and PGDH mRNA by RIA and Northern blotting analysis. F and dexamethasone decreased PGDH activity and mRNA levels. Exogenous P4 did not significantly alter PGDH activity or mRNA levels; however, MPA significantly stimulated PGDH activity. Trilostane decreased P4 production by more than 90% and also decreased PGDH activity and expression. Coincubation with P4 or MPA reversed trilostane inhibition of PGDH, consistent with a stimulatory role for endogenous P4 on PGDH. MPA significantly reversed F inhibition of PGDH activity and mRNA levels. In the presence of trilostane, P4 at equimolar concentration to F reversed F inhibition of PGDH mRNA levels. These findings suggest that F may be acting as an endogenous inhibitor of P4 action in the regulation of PGDH at term.
This article has been cited by other articles:
![]() |
A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parent, E. Madore, L. A MacLaren, and M. A Fortier 15-Hydroxyprostaglandin dehydrogenase in the bovine endometrium during the oestrous cycle and early pregnancy. Reproduction, March 1, 2006; 131(3): 573 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Duffy, B. L. Dozier, and C. L. Seachord Prostaglandin Dehydrogenase and Prostaglandin Levels in Periovulatory Follicles: Implications for Control of Primate Ovulation by Prostaglandin E2 J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1021 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Jerde, W. S. Mellon, S. M. Fischer, M. Liebert, D. E. Bjorling, and S. Y. Nakada Suppression of 15-Hydroxyprostaglandin Dehydrogenase Messenger RNA Concentration, Protein Expression, and Enzymatic Activity during Human Ureteral Obstruction J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 398 - 403. [Abstract] [Full Text] |
||||
![]() |
G. MASTORAKOS and I. ILIAS Maternal and Fetal Hypothalamic-Pituitary-Adrenal Axes During Pregnancy and Postpartum Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 136 - 149. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |